ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar NuclearSteve (< 20) Submitted: 12/29/2011 12:49:57 PM : Outperform Start Price: $1.11 ACAD Score: +18.08

Article from Zacks Biotech Guy - Jason Napodano - trying a strategy where I set 10% stops on all these and let the winners run.

Featured Broker Partners


Advertisement